Cantor Fitzgerald Begins Coverage on Omega Healthcare Investors (NYSE:OHI)

Key Points

• Omega Healthcare Investors was upgraded to a "strong-buy" rating by Cantor Fitzgerald, indicating a positive outlook from analysts.
• Multiple analysts have raised their price targets for Omega Healthcare Investors, with a consensus price target of $44.44 and an overall rating of "Moderate Buy."
• The company reported an earnings per share (EPS) of $0.77 for the latest quarter, significantly exceeding expectations, and had a year-over-year revenue increase of 11.8%.

Research analysts at Cantor Fitzgerald began coverage on shares of Omega Healthcare Investors (NYSE:OHI - Get Free Report) in a report released on Wednesday, Marketbeat Ratings reports. The firm set an "overweight" rating and a $50.00 price target on the real estate investment trust's stock. Cantor Fitzgerald's price target suggests a potential upside of 18.19% from the stock's current price.

Several other equities research analysts also recently issued reports on the company. Raymond James Financial restated an "outperform" rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Mizuho lifted their target price on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a research note on Thursday, September 11th. Wells Fargo & Company increased their price objective on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a report on Wednesday, August 27th. Truist Financial lifted their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research note on Wednesday, September 3rd. Finally, Scotiabank upped their price target on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a "sector perform" rating in a research note on Thursday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat.com, Omega Healthcare Investors has an average rating of "Moderate Buy" and a consensus target price of $44.44.

Omega Healthcare Investors Stock Performance

Shares of NYSE:OHI opened at $42.30 on Wednesday. The business's 50-day simple moving average is $41.33 and its 200 day simple moving average is $38.66. The company has a market cap of $12.48 billion, a P/E ratio of 26.11, a PEG ratio of 2.21 and a beta of 0.70. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. Omega Healthcare Investors has a one year low of $35.04 and a one year high of $44.42.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.32. The firm had revenue of $235.60 million during the quarter, compared to analysts' expectations of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.Omega Healthcare Investors's quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, sell-side analysts forecast that Omega Healthcare Investors will post 2.86 earnings per share for the current fiscal year.

Insider Activity at Omega Healthcare Investors

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction on Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director owned 18,654 shares in the company, valued at approximately $749,144.64. The trade was a 11.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.50% of the stock is currently owned by company insiders.

Institutional Trading of Omega Healthcare Investors

Several institutional investors have recently made changes to their positions in the stock. GAMMA Investing LLC lifted its position in Omega Healthcare Investors by 4,248.2% in the 1st quarter. GAMMA Investing LLC now owns 174,102 shares of the real estate investment trust's stock worth $6,630,000 after buying an additional 170,098 shares in the last quarter. Rhumbline Advisers boosted its position in Omega Healthcare Investors by 2.7% during the first quarter. Rhumbline Advisers now owns 797,469 shares of the real estate investment trust's stock valued at $30,368,000 after purchasing an additional 20,710 shares during the last quarter. NBC Securities Inc. bought a new stake in shares of Omega Healthcare Investors in the 1st quarter valued at approximately $29,000. Merit Financial Group LLC increased its holdings in Omega Healthcare Investors by 27.9% in the first quarter. Merit Financial Group LLC now owns 43,594 shares of the real estate investment trust's stock worth $1,660,000 after buying an additional 9,519 shares during the last quarter. Finally, RFG Advisory LLC bought a new position in Omega Healthcare Investors during the first quarter valued at approximately $1,161,000. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.